99% Savings - Buy Just @1 Rs X
Bilagra M is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Is the use of Bilagra M safe for pregnant women?
Bilagra M may have some side effects during pregnancy. Pregnant women should discontinue the use of Bilagra M, and talk to their doctor, if they notice any discomfort.
Is the use of Bilagra M safe during breastfeeding?
If you are breastfeeding, you may experience some harmful effects of Bilagra M. In case you experience any of these, discontinue its use until you consult your doctor.
What is the effect of Bilagra M on the Kidneys?
Bilagra M has very mild side effects on the kidneys.
What is the effect of Bilagra M on the Liver?
Bilagra M can have moderate side effects on the liver. If you notice any harmful effects then stop taking this drug right away. Consult your doctor before using this medicine again.
What is the effect of Bilagra M on the Heart?
Bilagra M may have mild side effects on the heart. Most people will never see any effect on the heart.
Bilagra M should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Bilagra M unless your doctor advises you to do so -
Is this Bilagra M habit forming or addictive?
Forming a habit of Bilagra M has not been reported.
Interaction between Food and Bilagra M
Due to a lack of research, nothing can be said about the consequences of taking Bilagra M together with food.
Interaction between Alcohol and Bilagra M
Consuming Bilagra M with alcohol can have many serious effects on your body.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 873-874
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 228
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Singulair® (montelukast sodium)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Lukair® (montelukast sodium)